2025 annual financial data
Alzamend Neuro 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -4,496,824 USD and net income was -4,514,853 USD.
Operating cash flow was -6,568,186 USD.
Get free Alzamend Neuro email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,496,824 USD
- Net income
- -4,514,853 USD
- Operating cash flow
- -6,568,186 USD